Bacteroides fragilis
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
An anaerobic Gram-negative rod and the most frequent anaerobe in serious infections; part of the normal colon flora.
Infections
Intra-abdominal abscess, diabetic foot and other polymicrobial wound infection, bloodstream infection.
Signs and symptoms
Fever and localized pain; foul-smelling discharge in wounds and abscesses.
Antibiotic and antimicrobial resistance
Produces beta-lactamases; resistance to clindamycin is common.
Treatment considerations
Metronidazole, beta-lactam/beta-lactamase inhibitor combinations or carbapenems, with drainage of abscesses.
Sources
- IDSA. Skin and Soft Tissue Infections guideline.
- IDSA / IWGDF. Diabetic Foot Infections guideline.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.